HDFC Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1568 Cr | ₹8161 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.14 | 1.82 |
Manager | Dhruv Muchhal | Sailesh Raj Bhan |
ISIN Code | INF179KC1HL7 | INF204K01968 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | -7.92% | -5.84% |
6 Month | -4.61% | -10.06% |
1 Year | 23.89% | 9.24% |
3 Year | - | 19.89% |
5 Year | - | 23.87% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | -7.48% | -8.53% |
1 Year | 5.84% | -6% |
3 Year | - | 20.95% |
5 Year | - | 18.24% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 51.48% | 18.19% |
3 Year | - | 20.5% |
5 Year | - | 20.36% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | - | 15.185% |
Sharp | - | 0.81% |
Beta | - | 0.931% |
Alpha | - | -0.33% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Dhruv Muchhal | Sailesh Raj Bhan |
Total AUM | ₹520687 Cr | ₹96086 Cr |
Fund Manage | 40 | 5 |
HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 4.17063 | 1.36231 |
Small Cap | 34.62211 | 27.13989 |
Large Cap | 35.27771 | 38.72112 |
Mid Cap | 25.92957 | 32.7767 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 2.46783 | 1.36231 |
Basic Materials | 2.03973 | - |
Healthcare | 95.49246 | 98.63771 |
Top Comparisons
Nippon India Banking & PSU Debt Fund- Growth Plan- Growth Option
3Y Returns6.13%
LIC MF Banking & PSU Debt Fund-Growth
3Y Returns5.97%
Kotak Flexicap Fund - Growth
3Y Returns16.35%
HSBC Flexi Cap Fund - Regular Growth
3Y Returns16.67%
FRANKLIN INDIA MONEY MARKET FUND-GROWTH
3Y Returns6.65%
UTI MMF-Discontinued - Regular Plan -Growth
3Y Returns6.41%
WhiteOak Capital Mid Cap Fund Regular Plan Growth
3Y Returns0%
ICICI Prudential MidCap Fund - Growth
3Y Returns20.19%